Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: Postal and telephone survey of travellers
Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: Postal and telephone survey of travellers
复制标题
DOI:
10.1136/bmj.313.7056.525
复制
发表时间:
1996-08-31
影响因子:
--
通讯作者:
Bradley, DJ
中科院分区:
文献类型:
--
作者:
Barrett, PJ;Emmins, PD;Bradley, DJ
Objective-To compare the frequency of adverse events, particularly neuropsychiatric effects, from mefloquine and from chloroquine plus proguanil as used for malaria chemoprophylaxis.Design-Retrospective questionnaire to travellers taking either regimen between November 1993 and February 1995; telephone interview with those reporting pronounced side effects.Setting-Travellers from Britain who consulted an advisory helpline.Subjects-1214 adults taking mefloquine and 1181 taking chloroquine plus proguanil.Main outcome Measures-Reported presence of and degree of disability from 12 neuropsychiatric and other symptoms, as assessed by the subjects and by referees and on the basis of behaviour change.Results-There were equal rates of any side effects (40%) and of stopping or changing medication. Overall, neuropsychiatric adverse events were significantly more common in travellers taking mefloquine. In all, 333 neuropsychiatric adverse events were reported by 1214 travellers taking mefloquine, compared with 189 such events in 1181 travellers taking proguanil plus chloroquine (P